trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Potential factors for the difference in contrast-induced nephropathy risk between intra-arterial and intravenous administration include contrast volume, patient hemodynamic stability, and the risk of atheroemboli.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
2 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that potential factors for the difference in contrast-induced nephropathy risk between intra-arterial and intravenous administration include contrast volume, patient hemodynamic stability, and the risk of atheroemboli?

Yes. Current literature supports the premise that differences in contrast-induced nephropathy risk between intra-arterial and intravenous administration are influenced by factors such as contrast volume, hemodynamic stability, and the route-specific risk of embolic events.

Verdict: SUPPORTED · 2 sources for, 0 against · Last checked

The analysis

The claim is specific and empirical regarding the mechanistic and procedural factors differentiating intra-arterial and intravenous contrast-induced nephropathy risk. Retrieved literature, particularly comparative studies and clinical reviews, discusses these exact risk determinants, including administration route differences, contrast volume, and atherosclerotic/hemodynamic variables.

Evidence for · 2
P0584A COMPARATIVE STUDY ON THE INCIDENCE OF CONTRAST INDUCED NEPHROPATHY FOLLOWING INTRA-ARTERIAL VERSUS INTRAVENOUS CONTRAST ADMINISTRATION
2020
This study compares intravenous versus intra-arterial contrast administration, evaluating factors such as contrast volume, baseline clinical characteristics, and hemodynamic risk parameters associated with contrast-induced nephropathy.
Get citation
Moideen, A. (2020). P0584A COMPARATIVE STUDY ON THE INCIDENCE OF CONTRAST INDUCED NEPHROPATHY FOLLOWING INTRA-ARTERIAL VERSUS INTRAVENOUS CONTRAST ADMINISTRATION. doi.org. https://doi.org/10.1093/ndt/gfaa142.p0584

See more details
More for · 1
Contrast-Induced Nephropathy.
2026
This review highlights the necessity of understanding the risk differences between intravenous and intra-arterial contrast medium administration alongside factors like contrast volume and patient clinical status.
Get citation
M, N., S, M., Y, S., & D, Y. (2026). Contrast-Induced Nephropathy.. doi.org. https://doi.org/10.3400/avd.ra.26-00063

What does the evidence say?

The claim is specific and empirical regarding the mechanistic and procedural factors differentiating intra-arterial and intravenous contrast-induced nephropathy risk. Retrieved literature, particularly comparative studies and clinical reviews, discusses these exact risk determinants, including administration route differences, contrast volume, and atherosclerotic/hemodynamic variables.

Receipt History
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work